Identification of Oligosaccharides in Human Milk Bound onto the Toxin A Carbohydrate Binding Site of Clostridium difficile
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The oligosaccharides in human milk constitute a major innate immunological mechanism by which breastfed infants gain protection against infectious diarrhea. Clostridium difficile is the most important cause of nosocomial diarrhea, and the C-terminus of toxin A with its carbohydrate binding site, TcdA-f2, demonstrates specific abolishment of cytotoxicity and receptor binding activity upon diethylpyrocarbonate modification of the histidine residues in TcdA. TcdA-f2 was cloned and expressed in E. coli BL21 (DE3). A human milk oligosaccharide (HMO) mixture displayed binding with TcdA-f2 at 38.2 respond units (RU) at the concentration of 20 μg/ml, whereas the eight purified HMOs showed binding with the carbohydrate binding site of TcdA-f2 at 3.3 to 14 RU depending on their structures via a surface plasma resonance biosensor. Among them, Lacto-N-fucopentaose V (LNFPV) and Lacto-N-neohexaose (LNnH) demonstrated tight binding to TcdA-f2 with docking energy of −9.48 kcal/mol and −12.81 kcal/mol, respectively. It displayed numerous hydrogen bonding and hydrophobic interactions with amino acid residues of TcdA-f2.
Abstract
The oligosaccharides in human milk constitute a major innate immunological mechanism by which breastfed infants gain protection against infectious diarrhea. Clostridium difficile is the most important cause of nosocomial diarrhea, and the C-terminus of toxin A with its carbohydrate binding site, TcdA-f2, demonstrates specific abolishment of cytotoxicity and receptor binding activity upon diethylpyrocarbonate modification of the histidine residues in TcdA. TcdA-f2 was cloned and expressed in E. coli BL21 (DE3). A human milk oligosaccharide (HMO) mixture displayed binding with TcdA-f2 at 38.2 respond units (RU) at the concentration of 20 μg/ml, whereas the eight purified HMOs showed binding with the carbohydrate binding site of TcdA-f2 at 3.3 to 14 RU depending on their structures via a surface plasma resonance biosensor. Among them, Lacto-N-fucopentaose V (LNFPV) and Lacto-N-neohexaose (LNnH) demonstrated tight binding to TcdA-f2 with docking energy of −9.48 kcal/mol and −12.81 kcal/mol, respectively. It displayed numerous hydrogen bonding and hydrophobic interactions with amino acid residues of TcdA-f2.
참고문헌 (37)
- Bartlett JG, "Historical perspectives on studies of Clostridium difficile and C. difficile infection", Clin. Infect. Dis, 46, pp.S4~S11 (2008)
- Black RE, "Where and why are 10 million children dying every year", Lancet, 361, pp.2226~2234 (2003)
- Bode L, "Human milk oligosaccharides: every baby needs a sugar mama", Glycobiology, 22, pp.1147~1162 (2012)
- Borgert CJ, "Synergism, antagonism, or additivity of dietary supplements: application of theory to case studies", Thromb. Res, 117, pp.123~132 (2005)
- Chaturvedi P, "Milk oligosaccharide profiles by reversedphase HPLC of their perbenzoylated derivatives", Anal. Biochem, 251, pp.89~97 (1997)
- Coppa GV, "Oligosaccharides in human milk during different phases of lactation", Acta Paediatr. Suppl, 88, pp.89~94 (1999)
- De Leoz MLA, "Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota", J. Proteome Res, 14, pp.491~502 (2015)
- Dingle T, "Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile", Glycobiology, 18, pp.698~706 (2008)
- Duleba K, "Clostridium difficile infection in children hospitalized due to diarrhea", Eur. J. Clin. Microbiol. Infect. Dis, 33, pp.201~209 (2014)
- Egerer M, "Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity", J. Biol. Chem, 282, pp.25314~25321 (2007)
- El-Hawiet A, "Binding of Clostridium difficile toxins to human milk oligosaccharides", Glycobiology, 21, pp.1217~1227 (2011)
- El-Hawiet A, "Recognition of human milk oligosaccharides by bacterial exotoxins", Glycobiology, 25, pp.845~854 (2015)
- Greco A, "Carbohydrate recognition by Clostridium difficile toxin A", Nat. Struct. Mol. Biol, 13, pp.460~461 (2006)
- Idota T, "Inhibition of cholera toxin by human milk fractions and sialyllactose", Biosci. Biotechnol. Biochem, 59, pp.417~419 (1995)
- Jangi S, "Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life", J. Pediatr. Gastroenterol. Nutr, 51, pp.2~7 (2010)
- Kobata A, "Structures and application of oligosaccharides in human milk", Proc. Jpn. Acad. Ser. B Phys. Biol. Sci, 86, pp.1~17 (2010)
- Liu B, "Human milk glycoproteins protect infants against human pathogens", Breastfeed. Med, 8, pp.354~362 (2013)
- Locascio RG, "Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation", J. Agric. Food Chem, 55, pp.8914~8919 (2007)
- Mitty RD, "Clostridium difficile diarrhea:pathogenesis, epidemiology, and treatment", Gastroenterologist, 2, pp.61~69 (1994)
- Morris GM, "Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function", J. Comput. Chem, 19, pp.1639~1662 (1998)
- Morrow AL, "Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea", J. Nutr, 135, pp.1304~1307 (2005)
- Newburg DS, "Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans", J. Anim. Sci, 87(13 Suppl), pp.26~34 (2009)
- Nguyen TT, "Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris", Biotechnol. Lett, 34, pp.831~838 (2012)
- Thi Thanh Hanh Nguyen, "Inhibition Effect of Flavonoid Compounds against Neuraminidase Expressed in Pichia pastoris", Biotechnology and Bioprocess Engineering, 19(1), pp.70~75 (2014), 한국생물공학회
- Nguyen TTH, "Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation. Bioorg", Med. Chem. Lett, 21, pp.3088~3091 (2011)
- Ninonuevo MR, "A strategy for annotating the human milk glycome. J. Agric", Food Chem, 54, pp.7471~7480 (2006)
- Ranalli A, "Antioxidizing potency of phenol compounds in olive oil mill wastewater", J. Agric. Food Chem, 51, pp.7636~7641 (2003)
- Roberts AK, "Modification of surface histidine residues abolishes the cytotoxic activity of Clostridium difficile toxin A", Toxicon, 39, pp.325~333 (2001)
- Sauerborn M, "The Cterminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality", FEMS Microbiol. Lett, 155, pp.45~54 (1997)
- Shang J, "Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance", Glycobiology, 23, pp.1491~1498 (2013)
- Smilowitz JT, "Breast milk oligosaccharides: structure-function relationships in the neonate", Annu. Rev. Nutr, 34, pp.143~169 (2014)
- Thi THN, "The influence of flavonoid compounds on the in vitro inhibition study of a human fibroblast collagenase catalytic domain expressed in E. coli", Enzyme Microb. Technol, 52, pp.26~31 (2013)
- Totten SM, "Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers", J. Proteome Res, 11, pp.6124~6133 (2012)
- Urashima T, "The predominance of type I oligosaccharides is a feature specific to human breast milk", Adv. Nutr, 3, pp.473s~482s (2012)
- Wallace AC, "Ligplot - a program to generate schematic diagrams of protein ligand interactions", Protein Eng, 8, pp.127~134 (1995)
- Wultanska D, "Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age", Med. Dosw. Mikrobiol, 62, pp.77~84 (2010)
- Zilberberg MD, "Increase in adult Clostridium difficile-related hospitalizations and casefatality rate, United States, 2000-2005", Emerg. Infect. Dis, 14, pp.929~931 (2005)